These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33216017)

  • 41. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.
    Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM
    Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of intra-procedural fusion imaging combining contrast-enhanced ultrasound using a perflubutane-based contrast agent and auto sweep three-dimensional ultrasound for guiding radiofrequency ablation and evaluating its efficacy in patients with hepatocellular carcinoma.
    Sanga K; Numata K; Nihonmatsu H; Ogushi K; Fukuda H; Chuma M; Hashimoto H; Koizumi N; Maeda S
    Int J Hyperthermia; 2020; 37(1):202-211. PubMed ID: 32070164
    [No Abstract]   [Full Text] [Related]  

  • 43. Parametric imaging with contrast-enhanced ultrasound: usefulness for characterization of dynamic effects of microvascularization for hepatocellular carcinoma and focal nodular hyperplasia.
    Zheng SG; Xu HX; Liu LN; Wang Y; Zhang YF; Guo LH; Liu C; Xu JM; Sun LP; Wu J
    Clin Hemorheol Microcirc; 2013; 55(3):375-89. PubMed ID: 23271200
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Savitzky-Golay filter based contrast-enhanced ultrasound quantification in hepatic tumors: Methodology and its correlation with tumor angiogenesis.
    Peng S; Ding H; Fu T; Wang B; Wang W; Zhou J
    Clin Hemorheol Microcirc; 2019; 73(2):271-282. PubMed ID: 30103307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fusion imaging of contrast-enhanced ultrasound and contrast-enhanced CT or MRI before radiofrequency ablation for liver cancers.
    Bo XW; Xu HX; Wang D; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K
    Br J Radiol; 2016 Nov; 89(1067):20160379. PubMed ID: 27626506
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic accuracy and interobserver variability of Dynamic Vascular Pattern (DVP) in primary liver malignancies - A simple semiquantitative tool for the analysis of contrast enhancement patterns.
    Schellhaas B; Waldner MJ; Görtz RS; Vitali F; Kielisch C; Pfeifer L; Strobel D; Janka R; Neurath MF; Wildner D
    Clin Hemorheol Microcirc; 2017; 66(4):317-331. PubMed ID: 28211805
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of contrast-enhanced ultrasound washout rate in predicting hepatocellular carcinoma differentiation.
    Feng Y; Qin XC; Luo Y; Li YZ; Zhou X
    Ultrasound Med Biol; 2015 Jun; 41(6):1553-60. PubMed ID: 25747937
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contrast-enhanced ultrasound (CEUS) prediction of focal liver lesions in patients after liver transplantation in comparison to histopathology results.
    Rübenthaler J; Paprottka KJ; Hameister E; Hoffmann K; Joiko N; Reiser M; Rjosk-Dendorfer R; Clevert DA
    Clin Hemorheol Microcirc; 2017; 66(4):303-310. PubMed ID: 28527201
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term study analysis of contrast-enhanced ultrasound in the diagnosis of focal nodular hyperplasia.
    Negrão de Figueiredo G; Mueller-Peltzer K; Schwarze V; Marschner C; Zhang L; Rübenthaler J; Siepmann T; Illigens BW; Clevert DA
    Clin Hemorheol Microcirc; 2020; 74(4):441-452. PubMed ID: 31743989
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
    Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
    J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of Liver Tumors Using Preoperative and Intraoperative Contrast-Enhanced Ultrasound (CEUS/IOCEUS) by Radiologists in Comparison to Magnetic Resonance Imaging and Histopathology.
    Huf S; Platz Batista da Silva N; Wiesinger I; Hornung M; Scherer MN; Lang S; Stroszczynski C; Fischer T; Jung EM
    Rofo; 2017 May; 189(5):431-440. PubMed ID: 28449169
    [No Abstract]   [Full Text] [Related]  

  • 52. Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted?
    Leoni S; Piscaglia F; Granito A; Borghi A; Galassi M; Marinelli S; Terzi E; Bolondi L
    Ultraschall Med; 2013 Jun; 34(3):280-7. PubMed ID: 23616066
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
    Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T
    Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of Contrast-Enhanced Ultrasound and Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI for the Diagnosis of Macroscopic Type of Hepatocellular Carcinoma.
    Iwamoto T; Imai Y; Kogita S; Igura T; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Seki Y; Ohashi H; Fujita N; Kudo M; Takehara T
    Dig Dis; 2016; 34(6):679-686. PubMed ID: 27750237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Focal liver lesions: sinusoidal phase of CEUS.
    D'Onofrio M; Martone E; Faccioli N; Zamboni G; Malagò R; Mucelli RP
    Abdom Imaging; 2006; 31(5):529-36. PubMed ID: 16802201
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot study.
    Cho YZ; Park SY; Choi EH; Baik SK; Kwon SO; Kim YJ; Cha SH; Kim MY
    Clin Mol Hepatol; 2015 Jun; 21(2):165-74. PubMed ID: 26157754
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria.
    Quaia E; De Paoli L; Angileri R; Pizzolato R; Cabibbo B; Cova MA
    Abdom Imaging; 2013 Dec; 38(6):1245-53. PubMed ID: 24026173
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lack of arterial hypervascularity at contrast-enhanced ultrasound should not define the priority for diagnostic work-up of nodules <2 cm.
    Forner A; Vilana R; Bianchi L; Rodríguez-Lope C; Reig M; García-Criado MÁ; Rimola J; Solé M; Ayuso C; Bru C; Bruix J
    J Hepatol; 2015 Jan; 62(1):150-5. PubMed ID: 25173969
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of computed tomography (CT) and contrast-enhanced ultrasound (CEUS) for the quantitative evaluation of an ablation defect following radiofrequency ablation of malignant liver lesions.
    Bruenn K; Beyer L; Haimerl M; Pregler B; Stroszczynski C; Jung EM; Wiggermann P
    Clin Hemorheol Microcirc; 2017; 67(3-4):445-451. PubMed ID: 28885212
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Integrating contrast-enhanced sonography in the follow-up algorithm of hepatocellular carcinoma treated with radiofrequency ablation: single cancer center experience.
    Catalano O; Izzo F; Vallone P; Sandomenico F; Albino V; Nunziata A; Fusco R; Petrillo A
    Acta Radiol; 2015 Feb; 56(2):133-42. PubMed ID: 24523360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.